Pre- and post-therapeutic evaluation of liver and spleen in type I and type III Gaucher's disease using diffusion tensor imaging. [PDF]
Alnaghy E, Razek AA, Abdelhalim E.
europepmc +1 more source
Gaucher’s Disease – current state of knowledge and future perspectives?
Introduction and purpose: Gaucher's Disease (GD), a rare genetic disorder, is a difficult challenge in genetic and metabolic disorders. The aim of this review is to provide an exploration of GD, spanning its pathophysiology to the latest advancements in
Katarzyna Szymańska +7 more
doaj +1 more source
Impact of Gba2 on neuronopathic Gaucher's disease and α-synuclein accumulation in medaka (Oryzias latipes). [PDF]
Nakanishi E +10 more
europepmc +1 more source
Macitentan in the treatment of pulmonary hypertension in Gaucher‚s disease. [PDF]
Taylan G +3 more
europepmc +1 more source
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease. The development of PD is closely linked to genetic and environmental factors, with GBA1 variants being the most common genetic risk.
Xuxiang Zhang +3 more
doaj +1 more source
Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease. [PDF]
Andrade-Campos MM +9 more
europepmc +1 more source
Beta Thalassemia Major with Gaucher's Disease: A Rare Entity. [PDF]
Bai N +4 more
europepmc +1 more source
Navigating gynaecological challenges in Gaucher's disease: insights from five European countries. [PDF]
Dominik L +3 more
europepmc +1 more source
Gaucher's Disease in an Adult Male: A Case Report of a Rare Mutation. [PDF]
Bhati AA +4 more
europepmc +1 more source
Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher's disease. [PDF]
Roca-Espiau M +6 more
europepmc +1 more source

